...
首页> 外文期刊>AJR: American Journal of Roentgenology : Including Diagnostic Radiology, Radiation Oncology, Nuclear Medicine, Ultrasonography and Related Basic Sciences >Tumor Heterogeneity on FDG PET/CT and Immunotherapy: An Imaging Biomarker for Predicting Treatment Response in Patients With Metastatic Melanoma
【24h】

Tumor Heterogeneity on FDG PET/CT and Immunotherapy: An Imaging Biomarker for Predicting Treatment Response in Patients With Metastatic Melanoma

机译:肿瘤异质性对FDG PET / CT和免疫疗法:一种用于预测转移性黑素瘤患者治疗反应的成像生物标志物

获取原文
获取原文并翻译 | 示例
           

摘要

OBJECTIVE. The purpose of this study is to evaluate the ability of quantitative F-18-FDG PET. parameters to predict outcomes of patients with malignant melanoma who have been treated with immune modulation therapy.
机译:客观的。 本研究的目的是评估定量F-18-FDG PET的能力。 预测免疫调制治疗治疗的恶性黑素瘤患者的参数。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号